217 related articles for article (PubMed ID: 19607727)
1. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.
Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
BMC Cancer; 2009 Jul; 9():237. PubMed ID: 19607727
[TBL] [Abstract][Full Text] [Related]
2. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
[TBL] [Abstract][Full Text] [Related]
4. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
[TBL] [Abstract][Full Text] [Related]
5. Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.
Yen CC; Chen YJ; Pan CC; Lu KH; Chen PC; Hsia JY; Chen JT; Wu YC; Hsu WH; Wang LS; Huang MH; Huang BS; Hu CP; Chen PM; Lin CH
World J Gastroenterol; 2005 Mar; 11(9):1267-72. PubMed ID: 15761962
[TBL] [Abstract][Full Text] [Related]
6. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
7. [Study on relationship between p63 expression and 3q27-q29 alteration in non-small cell lung cancer].
Yu Y; Garber ME; Schluens K; Pacyna-Gengelbach M; Petersen I
Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):419-22. PubMed ID: 21244795
[TBL] [Abstract][Full Text] [Related]
8. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.
Pei J; Balsara BR; Li W; Litwin S; Gabrielson E; Feder M; Jen J; Testa JR
Genes Chromosomes Cancer; 2001 Jul; 31(3):282-7. PubMed ID: 11391799
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.
Choi YW; Choi JS; Zheng LT; Lim YJ; Yoon HK; Kim YH; Wang YP; Lim Y
Lung Cancer; 2007 Jan; 55(1):43-51. PubMed ID: 17109992
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
11. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
Kang JU; Koo SH; Kwon KC; Park JW
Int J Oncol; 2010 Aug; 37(2):327-35. PubMed ID: 20596660
[TBL] [Abstract][Full Text] [Related]
12. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
[TBL] [Abstract][Full Text] [Related]
13. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting.
Brass N; Ukena I; Remberger K; Mack U; Sybrecht GW; Meese EU
Eur J Cancer; 1996 Jun; 32A(7):1205-8. PubMed ID: 8758254
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.
Wang J; Qian J; Hoeksema MD; Zou Y; Espinosa AV; Rahman SM; Zhang B; Massion PP
Clin Cancer Res; 2013 Oct; 19(20):5580-90. PubMed ID: 23908357
[TBL] [Abstract][Full Text] [Related]
15. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.
Beà S; Ribas M; Hernández JM; Bosch F; Pinyol M; Hernández L; García JL; Flores T; González M; López-Guillermo A; Piris MA; Cardesa A; Montserrat E; Miró R; Campo E
Blood; 1999 Jun; 93(12):4365-74. PubMed ID: 10361135
[TBL] [Abstract][Full Text] [Related]
16. Assessment of molecular events in squamous and non-squamous cell lung carcinoma.
Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L
Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066
[TBL] [Abstract][Full Text] [Related]
17. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
[TBL] [Abstract][Full Text] [Related]
18. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.
Comtesse N; Keller A; Diesinger I; Bauer C; Kayser K; Huwer H; Lenhof HP; Meese E
Int J Cancer; 2007 Jun; 120(12):2538-44. PubMed ID: 17290396
[TBL] [Abstract][Full Text] [Related]
19. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.
Garnis C; Lockwood WW; Vucic E; Ge Y; Girard L; Minna JD; Gazdar AF; Lam S; MacAulay C; Lam WL
Int J Cancer; 2006 Mar; 118(6):1556-64. PubMed ID: 16187286
[TBL] [Abstract][Full Text] [Related]
20. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
